Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
The at-home FluMist vaccine will be for patients ages 2 to 49 years old. Patients can place an order online, complete a ...
Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...
The U.S. Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter decongestants – from the market, citing evidence that it ...
Protection from shots like the flu vaccine typically takes a couple of weeks to kick in, so getting one now may offer ...
Commercial launch of neffy®(epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by ...
As bad as such addictions might sound, and as widespread as they are, the current global addiction is yet worse: the ...
MONTREAL and CHARLOTTE, N.C., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the third quarter ended September 30, 2024 and ...
Common decongestants may soon be pulled from shelves. The Food and Drug Administration (FDA) announced Wednesday its proposal ...
Phenylephrine is both the most common decongestant on pharmacy shelves, and arguably the worst at its job. Last year, the FDA ...